US Series A And B Funding Picked Up in H1. What Does That Mean For Funding In 2024?
This post was originally published on this site
Editors note: Next up we will look at the investors that have increased their pace at this stage in the first half of 2024.
Although Series A and B funding for U.S.-based companies picked up in H1 2024 — up 34% year over year — the uptick may be deceiving.
While total funding reached $31.5 billion — the highest amount invested at this stage in two years — that increase was concentrated in larger fundings and in two leading sectors — healthcare/biotech and AI.
That includes a $6 billion Series B to xAI, which accounts for much of the increase. Still, if we remove that funding, H1 2024 is still above the half-year funding amounts in 2023.
!function(e,n,i,s){var d=”InfogramEmbeds”;var o=e.getElementsByTagName(n)[0];if(window[d]&&window[d].initialized)window[d].process&&window[d].process();else if(!e.getElementById(i)){var r=e.createElement(n);r.async=1,r.id=i,r.src=s,o.parentNode.insertBefore(r,o)}}(document,”script”,”infogram-async”,”https://e.infogram.com/js/dist/embed-loader-min.js”);
Bottleneck at Series A
Since the second half of 2022, we found a Series A bottleneck based on an analysis of Crunchbase data. As the market tightened, seed-stage companies faced a more challenging environment in which to raise a Series A round. While all companies face this crunch, seed represents the largest absolute number of companies funded, as well as the stage with the least funding and lower revenues to manage through a tightened funding environment.
The recent uptick in Series A and Series B funding does not address that bottleneck.
Large rounds boost early stage
The increase at Series A and Series B fundings in the first half of 2024 was concentrated in larger funding at these stages. We looked at fundings by half-year both below and above the $50 million mark since 2018.
Large Series A rounds picked up in 2021 — the peak market. Those large rounds slowed every half year since, but increased in 2024.
Close to two-thirds of these large Series A companies in H1 2024 are in healthcare/biotech. The runner-up industry for large Series A rounds is artificial intelligence. Other sectors with large fundings in the low- to mid-single digits include Web3, energy and hardware.
!function(e,n,i,s){var d=”InfogramEmbeds”;var o=e.getElementsByTagName(n)[0];if(window[d]&&window[d].initialized)window[d].process&&window[d].process();else if(!e.getElementById(i)){var r=e.createElement(n);r.async=1,r.id=i,r.src=s,o.parentNode.insertBefore(r,o)}}(document,”script”,”infogram-async”,”https://e.infogram.com/js/dist/embed-loader-min.js”);
Series B rounds show a similar trajectory. Around the market peak, larger rounds of $50 million and above increased and slowed since the second half of 2022. Recently, they’ve begun to pick up.
Alongside the xAI megaround, the pick-up this year is led by healthcare/biotech as the leading industry followed by AI. Hardware, including semiconductor and robotics, is the third-largest sector for large Series B rounds.
!function(e,n,i,s){var d=”InfogramEmbeds”;var o=e.getElementsByTagName(n)[0];if(window[d]&&window[d].initialized)window[d].process&&window[d].process();else if(!e.getElementById(i)){var r=e.createElement(n);r.async=1,r.id=i,r.src=s,o.parentNode.insertBefore(r,o)}}(document,”script”,”infogram-async”,”https://e.infogram.com/js/dist/embed-loader-min.js”);
Concentrated bets
The increase in Series A and B fundings in H1 were concentrated in larger fundings and in two leading sectors; healthcare/biotech and AI.
Other sectors got short shrift.
There is a big gap between these two leading sectors and others. Financial services, e-commerce and shopping, and transportation sector amounts, for instance, were significantly down.
Despite the fact that funding was concentrated, there was a noticeable increase in large Series A round counts. That could be seen as a sign of optimism.
Related Crunchbase Pro list:
Further reading:
Illustration: Dom Guzman
